"$250K was a good price. For TOV."
They knew. And they took cash.
Not sure why the first report of it read like this:
"During the first quarter, 2015, we acquired two patents for cash totaling $277,500."
(It morphed into this eventually: "During the first quarter, 2015, we acquired two patents, U.S. Patent 6,153,069 Apparatus for Amperometric DiagnosticAnalysis and 6,413,411 Method and Apparatus for Amperometric Diagnostic Analysis, for cash totaling $250,000.")
And not sure why it took a year to receive and record the assignments:
"During the first quarter, 2016, we received transfer of these patents and filed same with the USPTO, registered in the name of one of the Company’s subsidiaries."
DECN appears to have neglected to mention the patent acquisitions in the press until March 14, 2016, the day it brought the current lawsuit.
On March 1, 2016 the DECN share price was $.17.
On March 17th it had doubled to $.34.
A Forbes contributor wrote about the suit and DECN managed to issue a press release about the article on the very same day...two days later the price hit $.61 intraday.
It could be argued that the suit was a lucrative endeavor for those who sold during that period. Those still holding at less than 2 cents today probably don't feel nearly as good about it.
"$250K was a good price. For TOV"....and just a few DECN investors.
BTW, do you know how the DECN legal team was paid? I was under the impression that they were paid in advance with Preferred shares (there was some reference by the Company to the creation of a "fund" with settlement proceeds) but rumor has it that they are on a contingency basis. I don't know how that works. If a lawyer is paid with a client's convertible preferred shares can they convert to common and sell whenever they like?
Sorry...feel free to ignore the fee questions....just thinking out loud.
But can it core A apple?
Yes Ralph, of course it can core A apple.
